Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 10.60% vs 6.40% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -20.15% vs 10.52% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -13.08% vs 94.35% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 18.47% vs -46.40% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Alnylam Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 10.60% vs 6.40% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 66.85% vs 17.26% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -20.15% vs 10.52% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 348.11% vs -292.31% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -13.08% vs 94.35% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10,765.22% vs -103.62% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 18.47% vs -46.40% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 104.23% vs 20.72% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






